Nuclear medicine in the prediction and detection of radiation associated normal tissue damage of kidney, brain, bone marrow and salivary glands

Nuclear Medicine Communications

Volumn 24, Issue 8, 2003, Pages 845-852

  Goethals, I ^a   Dierckx, R ^a   De Meerleer, G ^a   Gemmel, F ^a   De Neve, W ^a   Van De Wiele, C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW; BRAIN INJURY; COMPARATIVE STUDY; EDITORIAL; HUMAN; INJURY; KIDNEY FAILURE; METHODOLOGY; PROGNOSIS; RADIATION INJURY; RADIATION PROTECTION; RADIOTHERAPY; SALIVARY GLAND; SCINTISCANNING;

BONE MARROW; BRAIN INJURIES; HUMANS; KIDNEY FAILURE; PROGNOSIS; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY; SALIVARY GLANDS;

EID: 2342481922     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000084581.51410.46     Document Type: Editorial

References (72)

1. Markoe A-M, Brady L-W, Swartz C, Campbell O, Antoniades K. Radiation effects on renal function. Front Radiat Ther Oncol 1989; 23: 310-322.
2. Jaenke R, Robbins M, Bywaters T, Whitehouse E, Rezvani M, Hopewell J. Capillary endothelium. Target site of renal radiation injury. Lab Invest 1993; 68: 396-405.
3. Kadiri S, Ajayi S. Variability in the relationship between serum creatinine and creatinine clearance in hypertensives and normotensives with normal renal function. Afr J Med Med Sci 2000; 29: 93-96.
4. 99mTc-DTPA and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis 1990; 16: 224-235.
5. Jung K, Pergande M, SChimke E, Ratzmann K. Urine enzymes and low molecular weight proteins as indicators of diabetic nephropathy. Klin Wochenschr 1989; 67(suppl): 1727-1730.
6. Dantal J, Bigot E, Bogers W, et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994;: 7-14.
7. Russell C, Dubovsky E. Measurement of renal function with radionuclides. J Nucl Med 1989; 30: 2053-2057.
8. Summerville D, Potter C, Treves S. The use of radiopharmaceuticals in the measurement of glomerular filtraton rate: A review. In: Freeman L, ed. Nuclear Medicine annual 1990. New York: Raven Press, 1990: 191-221.
9. 99mTc-DMSA in patients with proximal tubular dysfunction. Eur J Nucl Med 1983; 8: 404-405.
10. 99mTc-DMSA clearance a useful marker of proximal tubular dysfunction? Eur J Nucl Med 1984; 9: 439-442.
11. 99mTc-DMSA scintigraphy in detection and follow up of radiation nephropathy. In: Schmidt H, Chambron J, eds. Nuclear medicine. Quantitative analysis in imaging and function. Stuttgart: Schattauer, 1990: 417-419.
12. Dewit L, Anninga J, Hoefnagel C, Nooijen W. Radiation injury in the human kidney: a prospective analysis using specific scintigraphic and biochemical endpoints. Int J Radiat Oncol Biol Phys 1990;: 977-983.
13. Dewit L, Verheij M, Valdés Olmos R, Arisz L. Compensatory renal response after unilateral partial and whole volume high-dose irradiation of the human kidney. Eur J Cancer 1993;A: 2239-2243.
14. Groshar D, Embon O, Frenkel A, Front D. Renal function and technetium-99m-dimercaptosuccinic acid uptake in single kidneys: the value of in vivo SPECT quantification. J Nucl Med 1991;: 766-768.
15. 51Cr-EDTA clearance. Nucl Med Commun 1999; 20: 829-832.
16. Gulaldi N, Kostakoglu L, Uzal D, et al. Impact of radiotherapy on normal brain tissue: semi-automated quantification of decrease in perfusion. Ann Nucl Med 2000; 14:17-23.
17. Chan Y, Leung S, King A, Choi P, Metreweli C. Late radiation injury to the temporal lobes: morphologic evaluation at MR imaging. Radiology 1999;: 800-807.
18. Meyers C, Geara F, Wong P-F, Morrison W. Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys 2000; 46: 51-55.
19. Tomio L, Romano M, Zanchin G, et al. Ultrarapid high-dose course of prophylactic cranial irradiation in small-cell lung cancer: evaluation of late neurological morbidity in 16 long-term survivors. Am J Clin Oncol 1998;: 84-90.
20. Rubin P, Constine L, Nelson D. Late effects of cancer treatment: radiation and drug toxicity. In: Perez C, Brady L-W, eds. Principles and practice of radiation oncology. Philadelphia: Lippincott, 1992: 124-161.
21. Levegrun S, Ton L, Debus J. Partial irradiation of the brain. Semin Radiat Oncol 2001;: 259-267.
22. Valk P, Dillon W. Radiation injury of the brain. Am J Neuroradiol 1991;: 45-62.
23. Rubin P, Gash D, Hansen J, Nelson D, Williams J-P. Disruption of the blood brain barrier as the primary effect of CNS irradiation. Radiother Oncol 1994;: 51-60.
24. Munter M, Karger C, Reith W, Schneider H, Peschke P, Debus J. Delayed vascular injury after single high-dose irradiation in the rat brain: histologic, immunohistochemical, and angiographic studies. Radiology 1999;: 475-482.
25. Roman D, Sperduto P. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995;: 983-998.
26. Thornton A, Sandler H, Haken R, et al. The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms. Int J Radiat Oncol Biol Phys 1992; 24: 767-775.
27. Grosu A, Feldmann H, Albrecht C, et al. 3-Dimensional irradiation planning in brain tumors. The advantages of the method and the clinical results. Strahlenther Onkol 1998;: 7-13.
28. Gross M, Weber W, Feldmann H, Bartenstein P, Schwaiger M, Molls M. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. Int J Radiat Oncol Biol Phys 1998; 41: 989-995.
29. Weber W, Bartenstein P, Gross M, et al. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumours. J Nucl Med 1997;: 802-808.
30. 11C)-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med 1997;: 517-522.
31. Mosskin M, Ericson K, Hindmarsh T, et al. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 1989; 30: 225-232.
32. Ogawa T, Shishido F, Kanno I, et al. Cerebral glioma: evaluation with methionine PET. Radiology 1993;: 45-53.
33. 123I)iodo-alpha-methyl tyrosine and SPECT. J Nucl Med 1989; 30: 110-112.
34. Massey V, Wallner K. Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys 1990;: 395-398.
35. Agbi C, Bernstein M, Laperriere N, Leung P, Lumley M. Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants. Int J Radiat Oncol Biol Phys 1992;: 321-326.
36. Bruehlmeier M, Roelcke U, Amsler B, et al. Effect of radiotherapy on brain glucose metabolism in patients operated on for low grade astrocytoma. J Neurol Neurosurg Psychiatry 1999;: 648-653.
37. Crossen J, Garwood D, Glatstein E, Neuwelt E. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 1994;: 627-642.
38. Armstrong C, Ruffer J, Corn B, De Vries K, Mollman J. Biphasic patterns of memory deficits following moderatedose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms. J Clin Oncol 1995;: 2263-2271.
39. 11C-deoxyglucose accumulation, CFS monoamine metabolites and neuropsychological test performance in patients and healthy subjects. J Neurol Neurosurg Psychiatry 1991; 54: 672-678.
40. Gross H, Kling A, Henry G, Herndon C, Lavretsky H. Local cerebral glucose metabolism in patients with long-term behavioral and cognitive deficits following mild traumatic brain injury. J Neuropsychiatry Clin Neurosci 1996; 8: 324-334.
41. Taphoorn M, Schiphorst A, Snoek F, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 1994;: 48-54.
42. Marks L, Friedman H, Kurtzburg J. Reversal of radiation-induced neutropenia by granulocyte colony-stimulating factor. Med Pediatr Oncol 1992; 20: 240-242.
43. MacManus M, Lamborn K, Khan W, Varghese A, Graef L, Knox S. Radiotherapy-associated neutropenia and thrombocytopenia: analysis of risk factors and development of a predictive model. Blood 1997; 89: 2303-2310.
44. Jefferies S, Rajan B, Ashley S, Traish D, Brada M. Haematological toxicity of cranio-spinal irradiation. Radiother Oncol 1998; 48: 23-27.
45. Casamassima F, Ruggiero C, Caramella D, Tinacci E, Villari N, Ruggiero M. Hematopoietic bone marrow recovery after radiation therapy: MRI evaluation. Blood 1989; 73: 1677-1681.
46. Cavenagh E, Weinberger E, Shaw D, White K, Geyer J. Hematopoietic marrow regeneration in pediatric patients undergoing spinal irradiation: MR depiction. Am J Neuroradiol 1995; 16: 461-467.
47. Orlandini G, Ruggiero L, Gulisano M, Ruggiero M, Villari N, Casamassima F. Magnetic resonance (MR) evaluation of bone marrow in vertebral bodies. Arch Ital Anat Embryol 1991; 96: 93-100.
48. Yankelevitz D, Henschke C, Knapp P, Nisce L, Fi Y, Cahill P. Effect of radiation therapy on thoracic and lumbar bone marrow: evaluation with MR imaging. Am J Roentgenol 1991;: 87-92.
49. Palestro C, Kim C, Vega A, Goldsmith S. Acute effects of radiation therapy on indium-111-labeled leukocyte uptake in bone marrow. J Nucl Med 1989; 30: 1889-1891.
50. Reske SN, Karstens JH, Gloeckner W, et al. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet 1989; 1: 299-301.
51. Sacks EL, Goris ML, Glatstein E, Gilbert E, Kaplan HS. Bone marrow regeneration following large field radiation: influence of volume, age, dose, and time. Cancer 1978; 42: 1057-1065.
52. Roland J, Servais J, Scalliet P, Vandevivere J, Brans B. Disseminated bone marrow metastases from primary breast cancer: detection and follow-up by radioimmune bone marrow scintigraphy. J Nucl Med 1995; 36: 1930-1931.
53. Higashi T, Fisher S, Brown R, Nakada K, Walter G, Wahl R. Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies. J Nucl Med 2000;: 2026-2935.
54. King M, Casarett G, Weber D. A study of irradiated bone. I. Histopathological and physiologic changes. J Nucl Med 1979; 20: 1149.
55. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980.
56. Hallahan D, Haimovitz-Friedman A, Kufe D, Fuks Z, Weichselbaum R. The role of cytokines in radiation oncology. Important Adv Oncol 1993;: 71-80.
57. Herskind C, Bamberg M, Rodemann H. The role of cytokines in the development of normal-tissue reactions after radiotherapy. Strahlenther Onkol 1998;: 12-15.
58. Reinhardt M, Kubota K, Yamada S, Iwata R, Yaegashi H. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J Nucl Med 1997; 38: 280-287.
59. Awad H. Early reacting tissues: the digestive tract. In: Awad H, ed. Radiation oncology. Dordrecht: Kluwer Academic, 1991: 291-322.
60. Eisbruch A, Ship JA, Martel MK, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Radiat Oncol Biol Phys 1996; 36: 469-480.
61. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;: 577-587.
62. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotidsparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 50: 695-704.
63. Awad H. The influence of X irradiation on the iodide-trapping mechanism of the human parotid gland. Br J Radiol 1959; 32: 259-262.
64. Tsujii H. Quantitative dose-response analysis of salivary function following radiotherapy using sequential RI-sialography. Int J Radiat Oncol Biol Phys 1985;: 1603-1612.
65. Valdés Olmos R, Hoefnagel C, van der Schoot J. Nuclear medicine in the monitoring of organ function and the detection of injury related to cancer therapy. Eur J Nucl Med 1993; 20: 515-546.
66. Kaneko M, Shirato H, Nishioka T, et al. Scintigraphic evaluation of long-term salivary function after bilateral whole parotid gland irradiation in radiotherapy for head and neck tumour. Oral Oncol 1998; 34: 140-146.
67. Kosuda S, Satoh M, Yamamoto F, Uematsu M, Kusano S. Assessment of salivary gland dysfunction following chemoradiotherapy using quantitative salivary gland scintigraphy. Int J Radiat Oncol Biol Phys 1999;: 379-384.
68. van Acker F, Flamen P, Lambin P, et al. The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy. Nucl Med Commun 2001; 22: 225-231.
69. McDonald S, Meyerowitz C, Smudzin T, Rubin P. Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction. Int J Radiat Oncol Biol Phys 1994; 29: 747-754.
70. Cooper RA, Cowan RA, Owens SE, et al. Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia? Eur J Nucl Med 1999; 26: 220-225.
71. Mateos JJ, Setoain X, Ferre J, et al. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours. Nucl Med Commun 2001; 22: 651-656.
72. Grotz KA, Wustenberg P, Kohnen R, et al. Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer - a prospective, randomized, placebo-controlled, double-blind study. Br J Oral Maxillofac Surg 2001; 39: 34-39.